Colomer Bosch, Ramon ramon.colomer@uam.es
Actividades
- Artículos 263
- Libros 4
- Capítulos de libro 5
- Congresos 95
- Documentos de trabajo 1
- Informes técnicos 4
- Proyectos de investigación 2
- Tesis dirigidas 11
- Patentes o licencias de software 0
High mechanical conditioning by tumor extracellular matrix stiffness is a predictive biomarker for anti-fibrotic therapy in HER2-negative breast cancer.
- Miguel Quintela‐Fandino
- Begoña Bermejo
- Esther Zamora
- Fernando Moreno
- José Á. García-Sáenz
- Sònia Pernas
- Noelia Martínez-Jáñez
- Desirée Jiménez
- Encarna Adrover
- Raquel Andrés
- Silvana Mourón
- María José Sánchez Bueno
- Luís Manso
- Gemma Viñas
- Emilio Alba
- Antonio Llombart‐Cussac
- Javier Cortés
- Cristina Tebar
- Denise J. Roe
- Adam Grant
- Adam Watson
- Rámón Colomer
- Ghassan Mouneimne
Clinical Cancer Research (p. 5094-5104) - 16/9/2024
- ISSN 15573265
- iMarina
Usefulness and real-world outcomes of next generation sequencing testing in patients with cancer: an observational study on the impact of selection based on clinical judgement
- Colomer, R
- Miranda, J
- Romero-Laorden, N
- Hornedo, J
- González-Cortijo, L
- Mouron, S
- Bueno, MJ
- Mondéjar, R
- Quintela-Fandino, M
Eclinicalmedicine - 1/6/2023
10.1016/j.eclinm.2023.102029 Ver en origen
- ISSN 25895370
Tumor P70S6K hyperactivation is inversely associated with tumor-infiltrating lymphocytes in triple-negative breast cancer
- Jimeno R, Mouron S, Salgado R, Loi S, Pérez-Mies B, Sánchez-Bayona R, Manso L, Martínez M, Garrido-García A, Serrano-Pardo R, Colomer R, Quintela-Fandino M
Clinical & Translational Oncology (p. 1124-1131) - 1/4/2023
Editor: Springer Science and Business Media Deutschland GmbH
10.1007/s12094-022-03006-3 Ver en origen
- ISSN 1699048X
- ISSN/ISBN 1699-3055
- Dialnet
- iMarina
Distribution of PD-L1, TROP2 and HER2-"lowness" in early triple-negative breast cancer: an opportunity for treatment de-escalation
- Bueno, MJ
- Mouron, S
- Caleiras, E
- Martínez, M
- Manso, L
- Colomer, R
- Quintela-Fandino, M
Clinical & Translational Oncology - 18/10/2023
10.1007/s12094-023-03329-9 Ver en origen
- ISSN 1699048X
Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial
- Johnston, SRD
- Toi, M
- O'Shaughnessy, J
- Rastogi, P
- Campone, M
- Neven, P
- Huang, CS
- Huober, J
- Jaliffe, GG
- Cicin, I
- Tolaney, SM
- Goetz, MP
- Rugo, HS
- Senkus, E
- Testa, L
- Del Mastro, L
- Shimizu, C
- Wei, R
- Shahir, A
- Munoz, M
- San Antonio, B
- AndrT, V
- Harbeck, N
- Martin, M
Lancet Oncology (p. 77-90) - 3/1/2023
10.1016/s1470-2045(22)00694-5 Ver en origen
- ISSN 14702045
Progress and oncological outcome of neoadjuvant therapy in breast cancer patients during a 10-year period
- Ballesteros AI
- López MP
- Mondejar R
- Pacheco-Barcia V
- Donnay O
- Hernández B
- Romero-Laorden N
- Doblado B
- Álvarez López RM
- Pérez-Fernández E
- Colomer R
Revista De Senologia Y Patologia Mamaria (p. 167-174) - 1/7/2022
Editor: Elsevier Doyma
10.1016/j.senol.2021.09.002 Ver en origen
- ISSN 02141582
- ISSN/ISBN 1578-1399
Peripheral Blood Mononuclear Cells Predict Therapeutic Efficacy of Immunotherapy in NSCLC
- Rogado, Jacobo
- Pozo, Fernando
- Troule, Kevin
- Miguel Sanchez-Torres, Jose
- Romero-Laorden, Nuria
- Mondejar, Rebeca
- Donnay, Olga
- Ballesteros, Anabel
- Pacheco-Barcia, Vilma
- Aspa, Javier
- Al-Shahrour, Fatima
- Alfranca, Arantzazu
- Colomer, Ramon
Cancers - 1/6/2022
Editor: MDPI
10.3390/cancers14122898 Ver en origen
- ISSN 20726694
- ISSN/ISBN 2072-6694
BERENICE Final Analysis: Cardiac Safety Study of Neoadjuvant Pertuzumab, Trastuzumab, and Chemotherapy Followed by Adjuvant Pertuzumab and Trastuzumab in HER2-Positive Early Breast Cancer
- Dang, Chau
- Ewer, Michael S.
- Delaloge, Suzette
- Ferrero, Jean-Marc
- Colomer, Ramon
- de la Cruz-Merino, Luis
- Werner, Theresa L.
- Dadswell, Katherine
- Verrill, Mark
- Eiger, Daniel
- Sarkar, Sriparna
- de Haas, Sanne Lysbet
- Restuccia, Eleonora
- Swain, Sandra M.;
Cancers - 1/6/2022
10.3390/cancers14112596 Ver en origen
- ISSN 20726694
The Homologous Recombination Deficiency Scar in Advanced Cancer: Agnostic Targeting of Damaged DNA Repair
- Pacheco-Barcia, Vilma
- Munoz, Andres
- Castro, Elena
- Ballesteros, Ana Isabel
- Marquina, Gloria
- Gonzalez-Diaz, Ivan
- Colomer, Ramon
- Romero-Laorden, Nuria;
Cancers - 1/6/2022
Editor: MDPI
10.3390/cancers14122950 Ver en origen
- ISSN 20726694
- ISSN/ISBN 2072-6694
Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for treatment with fluoropyrimidines
- Garcia-Alfonso, P
- Saiz-Rodriguez, M
- Mondejar, R
- Salazar, J
- Paez, D
- Borobia, A M
- Safont, M J
- Garcia-Garcia, I
- Colomer, R
- Garcia-Gonzalez, X
- Herrero, M J
- Lopez-Fernandez, L A
- Abad-Santos, F
Clinical & Translational Oncology (p. 483-494) - 1/3/2022
10.1007/s12094-021-02708-4 Ver en origen
- ISSN 1699048X
Safety of adjuvant treatment with pertuzumab plus trastuzumab after neoadjuvant anthracycline-based chemotherapy in patients with HER2-positive localized breast cancer: Updated …
- Chau Dang
- Michael S Ewer
- Suzette Delaloge
- Jean-Marc Ferrero
- Mark Verrill
- Ramon Colomer
- Claudia Vieira
- Luis de la Cruz Merino
- Jennifer Lucas
- Theresa L Werner
- Hannah Douthwaite
- Denise Bradley
- Maeve Waldron-Lynch
- Jennifer Eng-Wong
- Sandra M Swain
1/1/2018
- iMarina
Are Inflammatory Markers Predictive of Nivolumab Efficacy in Advanced Non-Small-Cell Lung Cancer (NSCLC)?
- J Rogado
- MD Fenor De La Maza
- V Pacheco-Barcia
- JM Serra
- P Toquero
- B Vera
- A Ballesteros
- R Mondejar
- O Donnay
- B Obispo
- R Colomer
- JM Sanchez-Torres
1/1/2017
- iMarina
Medicina de precisión en oncología: Éxitos y perspectivas bioéticas
- Ramón Colomer Bosch
Bioética Y Cáncer (p. 17-26) - 1/1/2020
- iMarina
Fatty acid metabolism in cancer cell survival: A new anti-cancer target
- Porta, Rut
- Colomer, Ramon
- Puig, Teresa;
Cell Respiration And Cell Survival: Processes, Types And Effects (p. 193-208) - 1/12/2011
- iMarina
Factores pronósticos y predictivos
- Alejandro Rojo
- Juan Fernando García García
- Lucía González Cortijo
- J Hornedo Muguiro
- Antonio González Martín
- Gloria Ortega Pérez
- Luis Cabañas
- Ramón Colomer Bosch
Tratado De Cáncer De Mama (p. 13-24) - 1/1/2008
- iMarina
Investigación clínica en el cáncer de mama
- Agustí Barnadas i Molins
- Ramón Colomer Bosch
Tratado De Cáncer De Mama (p. 131-143) - 1/1/2008
- iMarina
Phase IB/II trial of palbociclib and binimetinib in advanced triple-negative breast cancer with hyperactivation of ERK and/or CDK4/6
- Manso, Luis
- Cortes, Alfonso
- Cejalvo, Juan M.
- Morales, Serafin
- Saenz, Jose A. Garcia
- Colomer, Ramon
- Sanchez-Bayona, Rodrigo
- Silva, Jorge
- Guerra, Juan A.
- Malon, Diego
- Mouron, Silvana
- Caleiras, Eduardo
- Quintela-Fandino, Miguel;
Cancer Research (p. NULL-08) - 15/2/2022
10.1158/1538-7445.sabcs21-ot2-19-08 Ver en origen
- ISSN 00085472
Pertuzumab/trastuzumab in early stage HER2-positive breast cancer: 5-year and final analysis of the BERENICE trial
- Dang, C.
- Ewer, M. S.
- Delaloge, S.
- Ferrero, J-M.
- Colomer, R.
- de la Cruz Merino, L.
- Dadswell, K.
- Verrill, M.
- Eiger, D.
- Sarkar, S.
- de Haas, S.
- Restuccia, E.
- Swain, S. M.;
Annals Of Oncology (p. S38-S39) - 1/5/2021
10.1016/j.annonc.2021.03.057 Ver en origen
- ISSN 09237534
Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection (PH FDC SC) plus chemotherapy in HER2-positive early breast cancer (EBC): Safety results from the adjuvant phase of the randomised, open-label, multicentre phase III (neo)adjuvant FeDeriCa study
- Im, S-A.
- Tan, A. R.
- Mattar, A.
- Colomer, R.
- Stroyakovskii, D.
- Nowecki, Z.
- De Laurentiis, M.
- Pierga, J-Y.
- Jung, K. H.
- Schem, C.
- Aguila, C.
- Crnjevic, T. Badovinac
- Heeson, S.
- Shivhare, M.
- Alexandrou, A.
- Restuccia, E.
- Jackisch, C.;
Annals Of Oncology (p. S40-S41) - 1/5/2021
10.1016/j.annonc.2021.03.060 Ver en origen
- ISSN 09237534
Immune T-cell subpopulations from the peripheral blood of non-small cell lung cancer patients are associated with the efficacy of anti-PD-1 immunotherapy
- Rogado, J.
- Pozo, F.
- Troule, K.
- Sanchez-Torres, J. M.
- Romero Laorden, N.
- Mondejar Solis, R.
- Donnay Candil, O.
- Ballesteros Garcia, A. I.
- Pacheco-Barcia, V.
- Aspa, J.
- Al-Shahrour, F.
- Alfranca, A.
- Colomer, R.;
Annals Of Oncology (p. S999-S1000) - 1/1/2021
10.1016/j.annonc.2021.08.1889 Ver en origen
- ISSN 09237534
The Systemic Inflammation Response Index (SIRI) is a prognostic factor that correlates with tumor burden in advanced pancreatic cancer
- Pacheco-Barcia, V E
- France, T
- Asselah, J
- Mondejar, R
- Zogopoulos, G
- Serrano, R
- Donnay, O
- Rogado, J
- Del Campo, L
- Martinez, E
- Martin, E
- Arlanzon, C
- Ochoa, P
- Guo, K
- Barrena, G
- Colomer Bosch, R
ANNALS OF ONCOLOGY (p. S300-S300) - 1/9/2020
10.1016/j.annonc.2020.08.274 Ver en origen
- ISSN 09237534
Primary tumour location impacts oncological outcome of patients with resected colorectal liver metastases
- Pacheco-Barcia, V E
- Vera Cea, B
- Garrido, A
- Donnay, O
- Toquero Diez, P
- Mondejar, R
- Serrano, R
- Martin, E
- Romero Laorden, N
- di Martino, M
- Del Campo, L
- Colomer Bosch, R
ANNALS OF ONCOLOGY (p. S454-S454) - 1/9/2020
10.1016/j.annonc.2020.08.614 Ver en origen
- ISSN 09237534
The systemic inflammation response index (SIRI) predicts oncological outcome and correlates with tumor burden in metastatic pancreatic cancer.
- Pacheco Barcia, Vilma
- France, Talya
- Asselah, Jamil
- Mondejar, Rebeca
- Romero-Laorden, Nuria
- Zogopoulos, George
- Serrano, Rosario
- Donnay, Olga
- Rogado Revuelta, Jacobo
- Del Campo, Lourdes
- Martinez, Elia
- Martin-Perez, Elena
- Arlanzon, Carmen
- Guo, Katie
- Ochoa, Pilar
- Alcindor, Thierry
- Barrena Castello, Gabriel
- Colomer, Ramon
JOURNAL OF CLINICAL ONCOLOGY - 20/5/2020
- ISSN 0732183X
- iMarina
Excess weight and efficacy of anti-PD-1 antibodies in advanced cancer patients
- Rogado, J
- Romero Laorden, N
- Sanchez Torres, J M
- Ramos-Levi, A
- Pacheco-Barcia, V E
- Ballesteros Garcia, A I
- Arranz, R
- Lorenzo, A
- Gullon, P
- Garrido, A
- Serra, J M
- Donnay, O
- Adrados, M
- Costas, P
- Aspa, J
- Alfranca, A
- Mondejar, R
- Colomer Bosch, R
Annals Of Oncology - 1/10/2019
- ISSN 09237534
- iMarina
Association of efficacy of anti-PD-1 immunotherapy in patients with advanced cancer with immune-related adverse events (irAEs)
- Rogado Revuelta, Jacobo
- Romero-Laorden, Nuria
- Sanchez Torres, Jose Miguel
- Pacheco-Barcia, Vilma
- Ballesteros, Anabel
- Maria Ramos-Levi, Ana
- Arranz, Reyes
- Lorenzo, Alicia
- Gullon, Pedro
- Garrido Garcia, Ana
- Maria Serra, Jose
- Donnay, Olga
- Adrados, Magdalena
- Costas, Pablo
- Aspa, Javier
- Alfranca, Arantza
- Fenor De la Maza, Maria Dolores
- Mondejar, Rebeca
- Colomer, Ramon;
Journal Of Clinical Oncology - 1/1/2019
- ISSN 0732183X
- iMarina
CONTRIBUTION OF TRASTUZUMAB TO THE PROGNOSTIC IMPROVEMENT OF HER2-POSITIVE EARLY BREAST CANCER IN SPAIN
- Ciruelos, E.
- Alba, E.
- Lopez, R.
- Lluch, A.
- Martin, M.
- Arroyo, I
- Navarro, B.
- Carcedo, D.
- Colomer, R.
- Albanell, J.;
Value In Health (p. S18-S18) - 1/1/2018
10.1016/j.jval.2018.09.102 Ver en origen
- ISSN 10983015
[Generalized cutaneous-nodal metastatic spread as initial manifestation of the recurrence of a gastric adenocarcinoma]
- Sanchez-Munoz, A
- Gravalos Castro, C
- Colomer Bosch, R
- Garcia Velasco, A
- Garcia, J P
- Cortes-Funes, H
Revista Clinica Espanola (p. 597-598) - 1/1/2003
- ISSN 15781860
- iMarina
Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE)
- Johnston SRD, Harbeck N, Hegg R, Toi M, Martin M, Shao ZM, Zhang QY, Martinez Rodriguez JL, Campone M, Hamilton E, Sohn J, Guarneri V, Okada M, Boyle F, Neven P, Cortés J, Huober J, Wardley A, Tolaney SM, Cicin I, Smith IC, Frenzel M, Headley D, Wei R, San Antonio B, Hulstijn M, Cox J, O'Shaughnessy J, Rastogi P, monarchE Committee Members and Investigators
Journal Of Clinical Oncology (p. 3987-3998) - 1/12/2020
- ISSN 0732183X
- iMarina
A phase II study of sequential docetaxel followed by doxorubicin/cyclophosphamide as first-line chemotherapy for metastatic breast cancer
- Antón A, Hornedo J, Lluch A, Massuti B, Corral M, Colomer R
Clinical Breast Cancer (p. 286-91) - 1/1/2003
10.3816/cbc.2003.n.034 Ver en origen
- ISSN 15268209
Role of interferon alfa-2b in the induction and maintenance treatment of low-grade non-Hodgkin's lymphoma: results from a prospective, multicenter trial with double randomization
- Gonzalez Baron, Manuel
- Arranz, R
- Garcia-Alfonso, P
- Sobrino, P
- Zamora, P
- Carrion, R
- Garcia-Larana, J
- Perez, G
- Lopez, J
- Lavilla, E
- Lozano, M
- Rayon, C
- Colomer, R
- Baron, MG
- Baron, M G
- Flores, E
- Perez-Manga, G
- Fernandez-Ranada, JM
- Fernandez-Ranada, J M
Journal Of Clinical Oncology (p. 1538-1546) - 1/1/1998
Editor: American Society of Clinical Oncology
10.1200/jco.1998.16.4.1538 Ver en origen
- ISSN 0732183X
- ISSN/ISBN 0732-183X
- Dialnet
- iMarina
Phase I/II study of paclitaxel/cisplatin as first-line therapy for locally advanced head and neck cancer.
- Hitt, R
- Paz-Ares, L
- Hidalgo, M
- Colomer, R
- Brandariz, A
- Pena, M
- Alvarez-Vicent, J
- Hornedo, J
- Cortes-Funes, H;
Seminars In Oncology (p. S19-20) - 1/12/1997
- ISSN 00937754
- iMarina
Exploración de la biodiversidad marina para el descubrimiento de terapias inmuno-oncológicas innovadoras
- Dauden Tello, Esteban (Investigador/a)
- Muñoz Calleja, Cecilia (Investigador/a)
- Sanchez Madrid, Francisco (Investigador principal (IP))
- Colomer Bosch, Ramon (Investigador/a)
Ejecución: 01-03-2022 - 28-02-2025
Tipo: Nacional
Importe financiado: 594823,75 Euros.
- iMarina
Impacto de la implantación del tratamiento neoadyuvante del cáncer de mama en la práctica clínica habitual durante un periodo de diez años
- Ramón Colomer Bosch (Director) Doctorando: Ana Isabel Ballesteros García
14/3/2023
- iMarina
Predictores inmunológicos y clínicos de eficacia a tratamiento con anticuerpos monoclonales frente al receptor de muerte programada tipo 1 (anti PD-1) en cáncer no microcítico de pulmón
- Ramón Colomer Bosch (Director)
- Nuria Romero Laorden (Director) Doctorando: Jacobo Rogado Revuelta
6/3/2023
- iMarina
Índice de Respuesta Inflamatoria Sistémica (IRIS): Factor Pronóstico en el Cáncer de Páncreas
- Rebeca Mondéjar Solís (Director)
- Ramón Colomer Bosch (Director) Doctorando: Pacheco Barcia, Vilma Emilia
28/1/2021
- iMarina
Cambios en el perfil inmunohistoquímico tras tratamiento neoadyuvante en pacientes con cáncer de mama
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director)
- Miguel Martín Giménez (Director) Doctorando: Rebeca Mondéjar Solís
1/1/2016
- iMarina
El fenotipo basal-her2 en el cáncer de mama: caracterización clínico-molecular e implicaciones terapéuticas
- Colomer Bosch, Ramon (Autor o Coautor)
- Javier Abel Menéndez Menéndez (Director)
- Ramón Colomer Bosch (Director) Doctorando: Begoña Martín Castillo
1/1/2016
- iMarina
Efectos de la inhibición de la síntesis de ácidos grasos en la eficacia de los tratamientos antineoplásicos
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director) Doctorando: Alejandro Vázquez Martín
1/1/2007
- iMarina
Estudio fase i/ii con dosis altas de mitoxantrone y ciclofosfamida sin soporte hematopoyético para el tratamiento de tumores de alto riesgo y metastásicos
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director)
- Rafael Enríquez de Salamanca (Director) Doctorando: José Luis Pérez Gracia
1/1/2004
- iMarina
Características y evolución del cáncer de mama metástásico al diagnóstico: comparación con las recidivas del cáncer de mama inicialmente localizado
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director)
- Rafael Enríquez de Salamanca (Director) Doctorando: Antonio Jimeno Largo
1/1/2003
- iMarina
Importancia de la dosis de antraciclinas en el tratamiento adyuvante del cáncer de mama
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director)
- Rafael Enríquez de Salamanca Lorente (Director) Doctorando: María Luz Amador Muñoz
1/1/2002
- iMarina
Este/a investigador/a no tiene patentes o licencias de software.
Perfiles de investigador/a
-
ORCID
-
Publons
-
Scopus Author ID
-
Dialnet id